Document:

Document

Exhibit 4.15

DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES
EXCHANGE ACT OF 1934

DESCRIPTION OF CAPITAL STOCK

The following descriptions of Cimarex's capital stock and provisions of its amended and restated certificate of incorporation and amended and restated bylaws are summaries and are qualified by reference to the complete text of the amended and restated certificate of incorporation and amended and restated bylaws, each of which is attached as an exhibit to the Company’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission. 

Authorized capital stock

Cimarex's authorized capital stock consists of 200,000,000 shares of common stock, par value $0.01 per share, and 15,000,000 shares of preferred stock, par value $0.01 per share. As of January 31, 2021, Cimarex had 102,807,656 shares of common stock and 28,165 shares of preferred stock outstanding.

Common stock

Dividends may be paid on the Cimarex common stock out of assets or funds legally available for dividends, when and if declared by Cimarex's board of directors, subject to any preferential rights of preferred stock, if preferred stock of Cimarex is then outstanding. If Cimarex is liquidated, dissolved, or wound up, the holders of shares of Cimarex common stock will be entitled to receive the assets and funds of Cimarex available for distribution after payments to creditors and to the holders of any preferred stock, in proportion to the number of shares held by them.

Each share of Cimarex common stock entitles the holder of record to one vote at all meetings of stockholders and the votes are non-cumulative. The Cimarex common stock has no redemption, conversion, or subscription rights and does not entitle the holder to any preemptive rights. The outstanding shares of Cimarex common stock are duly authorized, validly issued, fully paid and nonassessable. Shares of Cimarex common stock do not have the benefit of any retirement or sinking fund.

Cimarex's common stock is registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, and is listed on the New York Stock Exchange (“NYSE”) under the symbol “XEC.”

Preferred Stock

Cimarex’s board of directors may issue preferred stock in one or more classes or series. Unless required by law or any stock exchange, the authorized shares of preferred stock will be available for issuance without further action by the holders of the common stock. Cimarex’s board of directors is able to determine, with respect to any series of preferred stock, the voting powers, and such designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations or restrictions thereof. As of January 31, 2021, Cimarex had designated and issued 28,165 shares of 8.125% Series A Cumulative Perpetual Convertible Preferred Stock, par value $0.01 per share. 

Anti-takeover effects of certain provisions of Delaware law, Cimarex’s amended and restated certificate of incorporation and amended and restated bylaws

The amended and restated certificate of incorporation and amended and restated bylaws of Cimarex provide for a classified board of directors with staggered terms, provide that the authorized number of directors may be changed only by resolution of the board of directors, allow the board of directors to fill vacancies and newly created directorships resulting from an increase in the authorized number of directors by an affirmative vote of a majority of the directors then in office, even if less than a quorum, or by a sole remaining director, provide for the ability of stockholders to remove directors only for cause and by the affirmative vote of a majority of the votes cast, restrict the ability of stockholders to take action by written consent, prevent stockholders from calling a special meeting of the stockholders and provide that certain provisions of the amended and restated certificate of incorporation and amended and restated bylaws may be amended only with the affirmative vote of the holders of at least 80% of the voting power of the shares entitled to vote at an election of directors and that the amended and restated bylaws may be amended by the affirmative vote of a majority of the board of directors.

The amended and restated bylaws of Cimarex provide that stockholders seeking to bring business before or to nominate candidates for election as directors at an annual meeting of stockholders must provide timely notice of their proposal in writing to the corporate secretary. To be timely, a stockholder's notice to the corporate secretary must be delivered to or mailed and received at the principal executive offices of Cimarex no later than the 90th day or earlier than the 120th day before the anniversary date of the preceding year's annual meeting. If, however, no meeting was held in the prior year or the date of the annual meeting has been changed by more than 30 days from the date contemplated in the notice of annual meeting, notice by the stockholder to be timely must be received by the 10th day following the earlier of the day on which notice of the date of the annual meeting was mailed or publicly disclosed. In the case of a special meeting of stockholders to elect directors, notice to the corporate secretary must be delivered to or mailed and received at the principal executive offices of Cimarex by the 10th day following the earlier of the day on which notice of the date of the special meeting was mailed or publicly disclosed. The amended and restated bylaws of Cimarex also specify requirements as to the form and content of a stockholder's notice. These provisions may preclude stockholders from bringing matters before an annual meeting of stockholders or from nominating directors at an annual meeting of stockholders or may discourage or defer a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of Cimarex.

The amended and restated certificate of incorporation of Cimarex provides that authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval, subject to various limitations imposed by the NYSE. These additional shares may be used for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of common stock and preferred stock could make it more difficult or discourage an attempt to obtain control of Cimarex by means of a proxy contest, tender offer, merger or otherwise.

In addition, the Delaware General Corporation Law (the “DGCL”), which applies to Cimarex as a corporation organized in the State of Delaware, imposes restrictions on business combinations with interested parties. Section 203 of the DGCL, an anti-takeover law, prevents Delaware corporations under certain circumstances from engaging in a “business combination” with an “interested stockholder” (generally, a holder of 15% or more of the outstanding voting stock of the corporation). A “business combination” includes a merger or sale of 10% or more of a company's assets. However, the above provisions of Section 203 do not apply if (1) the board of directors approves the transaction; (2) after the completion of the transaction that resulted in the stockholder becoming an “interested stockholder,” that stockholder owned at least 85% of the company's voting stock outstanding at the time the transaction commenced, excluding shares owned by officers and directors and certain employee benefit plans; or (3) on or after the date of the transaction, the business combination is approved by the board of directors and authorized at a meeting of stockholders by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the “interested stockholder.” These provisions of Delaware law and Cimarex’s certificate of incorporation and bylaws may have the effect of delaying, deferring or preventing a change in control of Cimarex, even if the change in control might be beneficial to Cimarex stockholders.Document

    Cimarex Energy Co.
    1700 Lincoln Street, Suite 3700
    Denver, Colorado 80203-4553

            

NOTICE OF GRANT OF PERFORMANCE STOCK UNITS
AND AWARD AGREEMENT (PERFORMANCE AWARD)

            

						
	Name:  <first_name> <last_name>
	
		
	Participant ID:  <emp_id>
	
		
	Plan:  2019 Equity Incentive Plan
	
		
	Date of Award:  December 10, 2020
	
		
	Number of shares of Restricted Stock:  <shares_awarded>
	
		
	Restriction Period Ends:  December 1, 2023	

By accepting this agreement online, you and Cimarex Energy Co. (the “Company”) agree that this restricted stock award is granted under and governed by the terms and conditions of the Company’s 2019 Equity Incentive Plan (the “Plan”) and the Award Agreement (the “Agreement”), both of which are attached and made a part of this document.  In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of the Agreement, the terms and conditions of the Plan will prevail.

    CIMAREX 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT    Page | 1 of 8

AWARD AGREEMENT

    1.    Grant of Performance Stock Units.  Pursuant to the Plan and subject to the terms and conditions of this Agreement, you are granted Performance Stock Units entitling you to receive the aggregate of from 0% to 100% of the Fair Market Value of a share of Common Stock payable in Common Stock, plus from 0% to 100% of the Fair Market Value of a share of Common Stock payable in cash pursuant to Section 6.1.5 of the Plan.  Upon the Company’s achievement of pre-determined objectives for a specified performance period, 0% to 200% of the shares of Restricted Stock shown in the Notice of Grant will vest (the “Vested Shares Equivalent”). To the extent that the percentage of Vested Shares Equivalent earned at the end of the Performance Period (as defined in Paragraph 3) is 100% or less you will earn that percentage of shares of Restricted Stock (the “Earned Restricted Stock”); however, to the extent that the percentage of Vested Shares Equivalent earned at the end of the Performance Period (as defined in Paragraph 3) exceeds 100% of the shares of Restricted Stock shown in the Notice of Grant, in addition to the Earned Restricted Stock you will receive an amount of cash equal to the Fair Market Value of such Vested Shares Equivalent in excess of the Fair Market Value of the Earned Restricted Stock (the “Cash-Settled Equivalent”). Cash will also be paid in lieu of the issuance of fractional shares of Common Stock.  Prior to the end of the Performance Period (as defined in Paragraph 3), the Restricted Stock may be evidenced in the manner the Company deems appropriate, including, without limitation, a book-entry registration or issuance of a stock certificate or certificates.  At the end of the Performance Period the shares will be disposed of as provided in Paragraph 7.

    2.    Voting Rights and Ordinary Cash Dividends.  Prior to the end of the Performance Period you are entitled to the voting rights of a holder of the Company’s common stock.

        During the Performance Period, the Company will accrue dividends on the maximum number of Vested Shares Equivalent that may vest pursuant to this grant for each dividend record date occurring during the Performance Period.  At the end of the Performance Period, the number of Vested Shares Equivalent earned by you will be calculated in accordance with paragraph 4 of this Agreement.  At that time you will receive the dividends accrued by the Company that are attributable to the Vested Shares Equivalent earned by you in accordance with such calculation.  Any dividends that are accrued on shares that are forfeited as a result of the calculation described in Paragraph 4 will also be forfeited and returned to the Company’s general funds.

    3.    Performance Period.  Except as provided in Paragraphs 5 and 6, the “Performance Period” shall be the three-year period ending on the date set forth under “Restriction Period Ends” as provided in the foregoing Notice of Award.  You may not sell, assign, transfer by gift or otherwise, pledge, hypothecate or otherwise dispose of, by operation of law or otherwise, any of the shares of Restricted Stock prior to expiration of the Performance Period.

    4.    Performance Goals.  The number of Vested Shares Equivalent will be determined at the end of the Performance Period and will be based upon the Company’s stock price performance relative to that of a defined peer group.  The peer group will be comprised of the exploration and production companies set forth on Appendix B, on both the first day of the Performance Period and on the last day of the Performance Period (the “Performance Peer Group”).  The calculation of the exact number of Vested Shares Equivalent earned shall be determined as follows:

a.    The calculated percentage difference between (i) and (ii), below:

(i)    the average (rounded to the second decimal place) of the per share closing price of the Company’s common stock (the “XEC Beginning Price”) and the common stock of each company in the Performance Peer Group over 30 trading days preceding the beginning of the Performance Period, and

    CIMAREX 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT    Page | 2 of 8

(ii)    the average (rounded to the second decimal place) of the per share closing price of the Company’s common stock (the “XEC Ending Price”) and the common stock of each company in the Performance Peer Group over 30 trading days preceding the end of the Performance Period.

b.    After determination of the percentage difference as provided in 4.a., the Company and the companies in the Performance Peer Group will be ranked from the highest percentage to the lowest percentage, with the highest percentage company ranked as first and the lowest percentage company as the last number of the total number of companies in the Performance Peer Group.  If during the Performance Period any member of the Performance Peer Group (i) declares bankruptcy, or (ii) is delisted and ceases to be traded on a national securities exchange, then it will remain in the Performance Peer Group and shall be ranked with any similarly-situated company in last place for purposes of this Section 4.b.

c.    The result obtained in 4.b. will serve as the basis for determining the percentage of Vested Shares Equivalent earned by you. The percentage of Vested Shares Equivalent earned by you will serve as the basis for determining the Earned Restricted Stock to be held by you in the form of Restricted Stock and the Fair Market Value of Cash-Settled Equivalent to be paid in cash, if any.  The applicable percentages of Vested Shares Equivalent to be paid-out in Earned Restricted Stock and Cash-Settled Equivalent are set forth on Appendix A to this Agreement.  For the Company’s rank under the column entitled “Relative Performance Rank” you will vest the percentage shown under the appropriate “Percent of Restricted Stock Vesting” column depending on whether (i) the XEC Ending Price is less than the XEC Beginning Price or (ii) the XEC Ending Price is equal to or greater than the XEC Beginning Price.  If at the end of the Performance Period there are fewer companies in the Performance Peer Group than at the beginning of the Performance Period, the relative performance rank will be adjusted so that the Company must be ranked first or second of the companies in the Performance Peer Group in order for you to achieve 200% of the award if the XEC Ending Price is equal to or greater than the XEC Beginning Price, or in order for you to receive 100% of the award if the XEC Ending Price is less than the XEC Beginning Price, and no shares will vest if the Company is ranked less than 31% of the companies in the Performance Peer Group, with the remaining vesting percentages adjusted by interpolation.
 
    5.    Termination of Employment.

        a.    Death or Disability.  If your employment with the Company terminates on account of death or disability (as defined below) prior to the end of the Performance Period, you will receive the number of Vested Shares Equivalent calculated in accordance with paragraph 4, except that the end of the Performance Period will be the date of death or disability.

            You will be considered disabled if you are (i) unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, or (ii) by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan covering employees of Cimarex.

        b.    Other Terminations.  If your employment is terminated, voluntarily or involuntarily, for any reason other than death or disability prior to the end of the Performance Period, your Restricted Stock will be forfeited.

    6.    Change in Control.  Upon the occurrence of a Change in Control, as defined in the Plan, you will receive the number of Vested Shares Equivalent calculated in accordance with paragraph 4, except that the end of the Performance Period shall be the date of the Change in Control.

    7.    Removal of Restrictions.  Upon expiration of the Performance Period, the Company will deliver to you the number of Vested Shares Equivalent, in the form of Earned Restricted Stock and/or Cash-Settled Equivalent, as applicable, computed in accordance with this Agreement.  In conformity with its insider trading 
    CIMAREX 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT    Page | 3 of 8

policy, Cimarex may elect to electronically deliver the shares to your account at a brokerage firm selected by the Company.  You shall forfeit and assign to the Company, without any consideration, any shares of Restricted Stock to which you are not entitled at the end of the Performance Period.

    8.    Withholding Taxes.  Unless you make other arrangements with the Company, the Company will withhold a number of shares of Earned Restricted Stock having a Fair Market Value (as defined in the Plan) on the date of payment equal to the minimum statutory total tax that could be withheld on the transaction.  You may also make arrangements with the Company to pay the amount of taxes required by law or to deliver to the Company previously owned shares of common stock having a Fair Market Value on the date of payment equal to the minimum statutory total tax.  In no event shall any form of payment made by you be permitted if it would result in an accounting charge with respect to shares delivered to pay such taxes, unless otherwise approved by the Company’s Compensation and Governance Committee.

    9.    Effect of Prohibited Transfer.  If any transfer of Vested Shares Equivalent is made or attempted to be made contrary to the terms of this Agreement, the Company will have the right to acquire, without the payment of any consideration, such Vested Shares Equivalent from you or your transferee, at any time before or after a prohibited transfer.  In addition to any other legal or equitable remedies it may have, the Company may enforce its rights to specific performance to the extent permitted by law and may exercise such other equitable remedies then available to it.  The Company may refuse for any purpose to recognize any transferee who receives Vested Shares Equivalent contrary to the provisions of this Agreement as a stockholder and may retain and/or recover all dividends on such Vested Shares Equivalent that were paid or payable subsequent to the date on which the prohibited transfer was made or attempted. 

    10.    Clawback. By accepting this Performance Award, you expressly agree that, in the event of an accounting restatement due to material noncompliance with financial reporting requirements under the U.S. federal securities laws, the Committee has the right to use reasonable efforts to recover from you this Performance Award, during the three-year period preceding the date on which the Company is required to prepare an accounting restatement.  This clawback policy will be interpreted in the best judgment of the Committee in a manner consistent with any applicable rules or regulations adopted by the Securities and Exchange Commission or the New York Stock Exchange Stock Market as contemplated by the Dodd-Frank Act.
    11.    Miscellaneous.

a.Adjustments.  Article IX of the Plan provides for certain adjustments to the number of shares of Common Stock covered by the Restricted Stock and other changes in connection with a reorganization or other changes to the Common Stock.
b.Restrictions on Common Stock.  Any shares of Common Stock acquired by you are subject to the Company’s Insider Trading Policy and may be subject to other restrictions on resale.  Any sale or other disposition of shares by you must be made in compliance with the Company’s Insider Trading Policy, in effect from time to time, securities law and other applicable legal requirements.
c.Electronic Delivery.  The Company may, in its sole discretion, decide to deliver any documents related to Restricted Stock awarded under the Plan or future Restricted Stock that may be awarded under the Plan by electronic means.  You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through any on-line or electronic system established and maintained by the Company or another third party designated by the Company.
d.Amendment or Modifications to the Agreement.  This Agreement constitutes the entire understanding of the parties on the subjects covered.  You expressly warrant that you are not accepting this Agreement in reliance on any promises, representations, or inducements other than those contained herein.  Modifications to this Agreement or the Plan may only be made in writing and signed by a duly authorized officer of the Company.
    CIMAREX 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT    Page | 4 of 8

e.Amendment or Termination of the Plan.  By accepting this Performance Award, you expressly warrant that you have received the Restricted Stock under the Plan, and have received, read and are familiar with the terms of the Plan.  You understand that the Plan is discretionary in nature and that it may be amended, suspended or terminated by the Company at any time.
f.Defined Terms.  Capitalized terms have the meaning set forth in the Plan or herein, as the case may be.
g.Compliance with Securities Laws.  This Agreement shall be subject to the requirement that if at any time counsel to the Company determines that the listing, registration or qualification of the shares of Restricted Stock upon any securities exchange or under any state or federal law, or the consent or approval of any governmental or regulatory body, is necessary as a condition of, or in connection with, the issuance or purchase of such shares thereunder, the Restricted Stock may not be awarded unless such listing, registration, qualification, consent or approval shall have been effected or obtained on conditions acceptable to the Company.  Nothing herein shall be deemed to require the Company to apply for, obtain, or keep current, any such listing, registration or qualification.
h.Construction; Severability.  The section headings contained herein are for reference purposes only and shall not in any way affect the meaning or interpretation of this Agreement.  The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.
i.Waiver.  Any provision contained in this Agreement may be waived, either generally or in any particular instance, by the Committee appointed under the Plan, but only to the extent permitted under the Plan.
j.Binding Effect.  Subject to the limits on the transferability of the Restricted Stock, this Agreement shall be binding upon and inure to the benefit of the Company and you and their respective heirs, executors, administrators, legal representatives, successors and assigns.
k.No Right to Continued Employment.  Nothing contained in this Agreement or the Plan shall be construed as giving you any right to remain employed by (or provide other service to) the Company, any Subsidiary or any Affiliated Entity.  The Company reserves the right to terminate your employment (or other service) at any time.
l.Notices.  Any notice required or permitted to be given under this Agreement shall be in writing and shall be delivered electronically, personally or mailed (U.S. Mail) by the Company to you at your then current address as maintained by the Company or such other address as you may advise the Company in writing.  Any such notice shall be deemed to have been given as of the second day after deposit in the United States mails, postage prepaid, properly addressed as set forth in this paragraph, in the case of a mailed notice, or as of the date delivered in the case of electronic or personal delivery.
m.Governing Law.  This Agreement and the Plan shall be governed by and construed in accordance with the laws of the State of Delaware except as superseded by applicable Federal law.

    CIMAREX 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT    Page | 5 of 8

Attachments:

These documents constitute part of a prospectus covering securities that have been registered under the Securities Act of 1933.
Cimarex Energy Co. 2019 Equity Incentive Plan
Summary of the Cimarex Energy Co. 2019 Equity Incentive Plan
Form 10-K and other periodic reports [SEC Filings]

[REST OF THE PAGE IS LEFT BLANK INTENTIONALLY]

    CIMAREX 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT    Page | 6 of 8

Appendix A
Cimarex Energy Co.
Performance Stock Unit Agreement

															
	Relative Performance Rank	XEC Ending Price Less Than XEC Beginning Price	XEC Ending Price Equal to or Greater Than XEC Beginning Price
		Percent of Restricted Stock Vesting	

Value Consideration
	

Percent of Restricted Stock Vesting
	

Value Consideration

	1-2	100%	Stock	200%	100% Stock/
100% cash
	3	87.5%	Stock	175%	100% Stock/
75% cash
	4-5	75%	Stock	150%	100% Stock/
50% cash
	6	62.5%	Stock	125%	100% Stock/
25% cash
	7-8	50%	Stock	100%	Stock
	9	37.5%	Stock	75%	Stock
	10	25%	Stock	50%	Stock
	11-16	0%	N/A	0%	N/A

    CIMAREX 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT    Page | 7 of 8

Appendix B
Cimarex Energy Co.
Performance Award Agreement

Performance Peer Group

(Initially consisting of the following companies, subject to adjustment as provided in 
Section 4 of this Performance Share Agreement)

									
		Apache Corporation (APA)	EOG Resources, Inc. (EOG)
		Cabot Oil & Gas Corporation (COG)	EQT Corporation (EQT)
		Cimarex Energy Co. (XEC)	Marathon Oil Corporation (MRO)
		ConocoPhillips (COP)	Ovintiv Inc. (OVV)
		CNX Resources Corporation (CNX)	Occidental Petroleum Corporation (OXY)
		Continental Resources, Inc. (CLR)	PDC Energy, Inc. (PDCE)
		Devon Energy Corporation (DVN)	Pioneer Natural Resources Company (PXD)
		Diamondback Energy, Inc. (FANG)	Range Resources Corporation (RRC)

    CIMAREX 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT    Page | 8 of 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]